Publications
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer2013 | First Faculty of Medicine
- Germline mutations 657del5 and 643C > T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women2012 | First Faculty of Medicine
- The CHEK2 c. 1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic2005 | First Faculty of Medicine
- High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area2005 | First Faculty of Medicine
- Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma2023 | First Faculty of Medicine, Central Library of Charles University, Faculty of Science
- Germline multigene panel testing of patients with endometrial cancer2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Science
- Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex2023 | First Faculty of Medicine, Faculty of Science
- ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk2023 | First Faculty of Medicine, Central Library of Charles University
- Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Polygenic risk score (PRS) and its potential for breast cancer risk stratification2023 | First Faculty of Medicine
Loading network view...